US authorities are planning to purchase a new drug against COVID-19, developed by the American company Pfizer. This is reported to the New York Times newspaper.
According to the US President, US President Joe Bayiden will spend more than five billion dollars on PAXLOVID tablets. It is noted that this drug is planned to be purchased for the treatment of ten million patients with coronavirus.
In Pfizer, they said that Paxlovid can be used to prevent coronavirus and treat patients with severe disease. He 89 percent reduces the risks of hospitalization or death after COVID-19 infection, noted in pharmaceutical companies.
Earlier, Roszdravnadzor gave permission of PFizer pharmaceutical company to conduct clinical tests of the effectiveness of the drug from COVID-19. In clinical trials, 90 Russians will take part over 18 years old, which houses contact with people with the symptoms of COVID-19. Among them will be residents of the Moscow region, St. Petersburg, Barnaul, Smolensk and other cities.